Atlanta pharmaceutical company Inhibikase plans $18 million IPO

Inhibikase Therapeutics was launched in 2008 as an entrepreneurial start-up in Atlanta with initial financial support from the Georgia Research Alliance.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 23, 2020 Category: Pharmaceuticals Authors: David Allison Source Type: news